Related Experiment Video
Updated: Dec 29, 2025

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Epimimetics: Novel Therapeutics Targeting Epigenetic Mediators and Modulators
1Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia; Department of Anatomy and Neuroscience, University of Melbourne, Parkville, Victoria, Australia.
Novel epimimetics are proposed to mimic or enhance epigenetic modifications for disease treatment. These drugs target epigenetic mechanisms, offering new therapeutic avenues for various conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Genetics
Background:
- Epigenetic alterations are linked to numerous diseases.
- Environmental exposures can influence disease through epigenetic mechanisms.
- Targeted drugs for epigenetic components are emerging.
Purpose of the Study:
- To propose the development of novel drugs called 'epimimetics'.
- To design drugs that mimic or enhance the therapeutic effects of epigenetic modifications.
Main Methods:
- Drug development targeting specific epigenetic components.
- Investigating mechanisms of epigenetic modifications.
Main Results:
- The proposed epimimetics aim to leverage epigenetic pathways for therapeutic benefit.
- This approach could offer new treatment strategies for epigenetic-related diseases.
Conclusions:
- Epimimetics represent a promising new class of drugs.
- Targeting epigenetic modifications offers a novel therapeutic strategy for disease management.
More Related Videos
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Histone Modification
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...